HCKT trades 58.7% below Wall Street's consensus target of $16.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HCKT achieves its forward estimates and maintains a stable P/E multiple of 6.9x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, The Hackett Group, Inc. (HCKT) has a Wall Street consensus price target of $16.50, based on estimates from 5 covering analysts. With the stock currently trading at $10.40, this represents a potential upside of +58.7%. The company has a market capitalization of $262M.
Analyst price targets range from a low of $16.00 to a high of $17.00, representing a 6% spread in expectations. The median target of $16.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HCKT trades at a trailing P/E of 22.1x and forward P/E of 6.9x. The forward PEG ratio of 0.31 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +168.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $24.31, with bear and bull scenarios of $15.32 and $32.03 respectively. Model confidence stands at 41/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
FORRForrester Research, Inc. | $128M | $6.70 | — | — | Hold | 8.8x | 4 |
CRAICRA International, Inc. | $896M | $138.70 | $194.00 | +39.9% | Buy | 16.8x | 1 |
HURNHuron Consulting Group Inc. | $1.5B | $90.56 | $157.50 | +73.9% | Buy | 10.2x | 9 |
ICFIICF International, Inc. | $1.2B | $66.51 | $90.00 | +35.3% | Buy | 9.5x | 13 |
MANUManchester United plc | $3.9B | $22.37 | $17.95 | -19.8% | Hold | — | 10 |
EXLSExlService Holdings, Inc. | $4.1B | $25.93 | $40.25 | +55.2% | Buy | 11.6x | 19 |
ACNAccenture plc | $80.3B | $130.54 | $236.31 | +81.0% | Buy | 9.4x | 53 |
GGenpact Limited | $4.8B | $28.25 | $42.00 | +48.7% | Hold | 6.9x | 40 |
ITGartner, Inc. | $8.5B | $127.49 | $176.10 | +38.1% | Hold | 9.3x | 18 |
MANManpowerGroup Inc. | $1.6B | $33.55 | $37.86 | +12.8% | Hold | 9.1x | 29 |
Quick answers to the most common questions about buying HCKT stock.
The consensus Wall Street price target for HCKT is $16.5, representing 58.7% upside from the current price of $10.4. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HCKT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $16.5 implies 58.7% upside from current levels.
With a forward P/E of 6.9333x, HCKT trades at a relatively low valuation. The consensus target of $16.5 implies 58.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $17 for HCKT, while the most conservative target is $16. The consensus of $16.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $32 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
HCKT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HCKT stock forecast based on 5 Wall Street analysts shows a consensus price target of $16.5, with estimates ranging from $16 (bear case) to $17 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $24, with bear/bull scenarios of $15/$32.
Our quantitative valuation model calculates HCKT's fair value at $24 (base case), with a bear case of $15 and bull case of $32. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.
HCKT trades at a forward P/E ratio of 6.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on HCKT, with a "Buy" consensus rating and $16.5 price target (58.7% upside). 5 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HCKT analyst price targets range from $16 to $17, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16.5 consensus represents the middle ground. Our model's $15-$32 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.